Search
+
    SEARCHED FOR:

    PRISM MEDICO AND PHARMACY LTD Q4 RESULTS

    Apollo Hospitals shares rise 4% after reporting 83% YoY jump in Q1 PAT. Should you buy?

    Apollo Hospitals Share Price: Apollo Hospitals' stock saw a 4.2% increase after reporting a Q1 FY25 net profit of Rs 305 crore, up from Rs 167 crore last year. Revenue grew by 15% to Rs 5,086 crore. Several brokerage firms maintained positive ratings, highlighting improvements in occupancy and revenue segments.

    Apollo Hospitals Q1 Results: Profit zooms 83% YoY to Rs 305 crore, revenue up 15%

    Apollo Hospitals Q1 Results: Leading hospital chain Apollo Hospitals reported 83% growth in its consolidated net profit at Rs 305 crore for the first quarter ended June 2024. It was Rs 167 crore in the year-ago period.

    Stock picks of the week: 4 stocks with consistent score improvement and upside potential of up to 35%

    After many months or one may even say that after a gap of a year, Indian markets got a reminder that global markets also matter. But there are some good learnings from this week's episode. After all the volatility we are still the best performing market, so bears will have to wait before they can make any serious attempt to control the street. But because valuations are high, it would be better to still be cautious both the amount of exposure one is taking and more importantly the stocks which one is buying should have good fundamentals and the score should have seen some improvement. These selected stocks depict a strong upward trajectory in their overall average score. This implies that there has been a significant improvement in their market outlook in the given time frame.

    Tata Consumer shares drop over 2% as Q1 results fail to impress. Should you invest?

    Tata Consumer Products reported an 8% drop in profit after tax for the first quarter ended June 2024, falling to Rs 290 crore, below estimates. Shares fell 2.3%. Revenue from operations increased 16% year-on-year to Rs 4,352 crore. The drop in profit was attributed to higher exceptional items and lower returns from joint ventures and associates.

    Apollo Hospitals Q4 Results: Net profit rises 76% YoY to Rs 254 crore

    Revenue grew 15% YoY to Rs.4,944 crore in Q4FY24. The earnings before interest, tax, depreciation and ammortisation (EBITDA), EBITDA rose 31% YoY to Rs.640 crore in Q4FY24. The EBITDA margins expanded 161 basis points YoY to 12.95%.

    Apollo Hospitals Q4 Results: Net profit soars 77% YoY to Rs 258 crore; revenue jumps 15%

    Apollo Hospitals Q4 Results: Revenue from operations for the January-March 2024 period increased 15% YoY to Rs 4,944 crore. The company's board has recommended a final dividend of Rs 10 per share for FY24. EBITDA for the fourth quarter stood at Rs 640 crore in the reporting March quarter, compared with Rs 488 crore in the same quarter a year earlier.

    The Economic Times
    BACK TO TOP